Griffith Donald J. 4
4 · Sonnet BioTherapeutics Holdings, Inc. · Filed Feb 17, 2023
Insider Transaction Report
Form 4
Griffith Donald J.
DirectorChief Financial Officer
Transactions
- Award
Common Stock
2022-12-09+3,214→ 10,798 total - Tax Payment
Common Stock
2023-02-06$1.04/sh−497$518→ 10,301 total
Footnotes (2)
- [F1]On December 9, 2022, the Reporting Person was granted 3,214 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on January 1, 2024.
- [F2]Includes unvested restricted stock units.